Loading...
XASX
LGP
Market cap14mUSD
Jul 09, Last price  
0.07AUD
1D
1.45%
1Q
-27.84%
IPO
-84.78%
Name

Little Green Pharma Ltd

Chart & Performance

D1W1MN
XASX:LGP chart
P/E
P/S
0.50
EPS
Div Yield, %
Shrs. gr., 5y
18.98%
Rev. gr., 5y
80.67%
Revenues
42m
+15.21%
25854,447248,5002,204,0217,003,63014,039,89419,567,85836,824,00042,425,000
Net income
-1m
L
-217,154-3,757,810-5,518,129-8,276,400-4,356,471-24,068,953-9,205,4293,324,000-1,408,000
CFO
39k
P
-25,241-1,570,534-3,321,403-6,048,567-5,149,580-17,168,216-6,940,170-917,00038,999

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Little Green Pharma Ltd, established in 2016 and based in West Perth, Australia, specializes in the worldwide cultivation, manufacturing, and distribution of medicinal cannabis products. Its extensive product range encompasses cannabis flower medicines, various cannabis extracts, tinctures, and active pharmaceutical ingredients (APIs), serving markets both within Australia and internationally.
IPO date
Feb 20, 2020
Employees
120
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2026‑032025‑032023‑032022‑032021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT